Related Experiment Video
Updated: Sep 15, 2025
08:41
Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions
Published on: August 14, 2021
8.9K
Neuromuscular junction and the complement system.
1Institute of Immunology and Immunotherapy, University of Birmingham, United Kingdom; University Hospitals Birmingham, Birmingham, United Kingdom.
International Review of Neurobiology
|July 17, 2025
Summary
Complement inhibition shows promise for generalized myasthenia gravis (MG) by preventing acetylcholine receptor (AChR) antibody-induced neuromuscular junction damage. Therapies targeting complement protein 5 (C5) are advancing, with potential long-term benefits for MG patients.
Area of Science:
- Neurology
- Immunology
- Pharmacology
Background:
- Generalized myasthenia gravis (MG) is often caused by acetylcholine receptor (AChR) antibodies.
- These antibodies trigger complement activation, leading to neuromuscular junction (NMJ) destruction via the membrane attack complex (MAC).
- Experimental models confirm complement's role in MG pathogenesis.
Purpose of the Study:
- To review the development and efficacy of complement inhibitory therapies for generalized myasthenia gravis.
- To highlight the mechanisms of action and potential benefits of targeting the complement system in MG.
- To discuss safety considerations and future directions for complement-based treatments in MG.
Main Methods:
- Review of scientific literature on complement pathways in MG.
- Analysis of experimental autoimmune MG (EAMG) models.
- Summary of clinical trial data for anti-complement therapies targeting C5.
Main Results:
- Nearly 90% of MG patients have IgG1 or IgG3 anti-AChR antibodies.
- Complement inhibition, particularly C5 blockade, prevents MAC formation and NMJ destruction.
- Several anti-complement therapies (eculizumab, zilucoplan, etc.) show long-term benefits in MG subgroups.
- Vaccination and prophylactic antibiotics may be needed due to infection risk.
Conclusions:
- Complement inhibition is a promising therapeutic strategy for generalized MG.
- Targeting C5 effectively mitigates complement-mediated NMJ damage.
- Further research into biomarkers may optimize patient selection for complement-based therapies.
More Related Videos
Related Concept Videos
01:19The Neuromuscular Junction
11.7K
The nervous system consists of complex motor neuron circuits, including upper motor neurons originating from the cerebral cortex and lower motor neurons starting in the spinal cord, coordinating both voluntary and involuntary movements. Among these, somatic motor neurons activate skeletal muscles and are classified into alpha, beta, and gamma types. Alpha neurons are vital for voluntary movement coordination, while gamma neurons adjust muscle spindle sensitivity, and the function of beta...
11.7K
01:27Complement System
2.7K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.7K
01:29Neuromuscular Junction And Blockade
3.7K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.7K
01:26Chemical Synapses
9.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.2K
01:29Relaxation of Skeletal Muscles
3.8K
The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
3.8K
01:21Nervous System
2.3K
The nervous system coordinates body functions through its complex network of nerve cells, enabling sensation and movement. It is divided into two primary parts: the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS is composed of the brain and the spinal cord. The brain acts as the body's control center, processing sensory information and coordinating responses. The spinal cord functions as a major signaling pathway for the brain and the rest of the body.
2.3K